Description
Seeking men and women with urothelial (renal pelvis, ureter, bladder, or urethra) cancer that has spread to other places in the body (metastatic) for a study of an investigational drug combination.
Overview
Participants in this study will either get the investigational drug added to the usual treatment or the usual treatment alone. The investigational drug is a tablet taken by mouth and the usual treatment is an IV infusion given every 2 weeks for up to 2 years
What we're hoping for
We are studying whether adding an investigational drug to the usual treatment for urothelial (renal pelvis, ureter, bladder, or urethra) cancer that has spread to other places in the body (metastatic) helps to control the cancer.
Additional Information
ClinicalTrials.gov Identifier: NCT05092958